A study by the Evernorth Research Institute looking at national prescription drug use trends found GLP-1 use between 2023-2024 rose 84.6% in Gen Alpha (ages 14 and younger). The age group was ...

Costly GLP-1 drug use for weight loss has soared, study reports. ... GLP-1 drug use rose from 0.1% of the population in 2018 to 0.4% ... Moderna's new flu shot shows strong results in older adults ...

Real-world results for blockbuster weight-loss meds like Ozempic, Wegovy and Zepbound aren't as impressive as those promised by the drugs' clinical trials, a new study says.

Eli Lilly has seen positive results from a phase 3 trial of Orforglipron, the first-ever GLP-1 pill for weight loss and type 2 diabetes. Previous versions were administered via injection.

Many of the GLP-1 patients in their study also never reached the maximum dose. Chhabra also suspects that many people in the real world aren’t getting the supportive care and follow-up they ...

Please use one of the following formats to cite this article in your essay, paper or report: APA. Sai Lomte, Tarun. (2025, May 14). GLP-1 weight loss drugs leave users low on key nutrients, study ...

In total, the researchers identified 46,409 patients whose records indicated fibromyalgia diagnoses and at least two instances of GLP-1 drug use, along with 716,185 fibromyalgia patients with no ...

WASHINGTON, DC – June 17, 2025 – Sleeve gastrectomy and gastric bypass were associated with about five-times more weight loss than weekly injections of GLP-1 receptor agonists semaglutide or ...

In a matched group of more than 170,000 adults, those treated with GLP-1 agonists had a lower risk of developing an obesity-related cancer over a median follow-up of about 4 years when compared ...

GLP-1 drugs like Ozempic are associated with a higher risk of developing wet age-related macular degeneration in people with type 2 diabetes, according to a new study. The risk increased the ...

A recent study, published in JAMA Ophthalmology and conducted by University of Toronto researchers, found that diabetes patients who use GLP-1 drugs were twice as likely to develop neovascular age ...

About 12% of Americans say they have ever taken a GLP-1 drug, ... Head-to-head study shows bariatric surgery superior to GLP-1 drugs for weight loss (2025, June 17) ...